Exc
Image source: Getty Images.
What: Shareholders of the biotech company Tesaro (NASDAQ: TSRO) are likely smiling from ear to ear today. Tesaro’s stock has more than doubled today, up 111% as of 11:30 a.m. EST on exceptionally high volume, after the company reported strong data from a pivotal phase 3 ovarian cancer trial.